J.W. Burns & Co’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
26,774
-315
-1% -$18.1K 0.16% 84
2026
Q1
$1.64M Sell
27,089
-1,103
-4% -$64.3K 0.19% 80
2025
Q4
$1.52M Sell
28,192
-1,697
-6% -$81.6K 0.17% 83
2025
Q3
$1.35M Sell
29,889
-1,799
-6% -$84K 0.15% 89
2025
Q2
$1.47M Sell
31,688
-950
-3% -$46.6K 0.18% 84
2025
Q1
$1.99M Sell
32,638
-100
-0.3% -$5.83K 0.26% 72
2024
Q4
$1.85M Sell
32,738
-726
-2% -$40.6K 0.24% 73
2024
Q3
$1.73M Sell
33,464
-2,114
-6% -$99.2K 0.23% 74
2024
Q2
$1.48M Sell
35,578
-4,898
-12% -$219K 0.2% 75
2024
Q1
$2.19M Sell
40,476
-12,714
-24% -$648K 0.31% 69
2023
Q4
$2.73M Sell
53,190
-2,065
-4% -$108K 0.4% 57
2023
Q3
$3.21M Sell
55,255
-1,170
-2% -$71.7K 0.52% 51
2023
Q2
$3.61M Sell
56,425
-464
-0.8% -$31.1K 0.58% 49
2023
Q1
$3.94M Buy
56,889
+49
+0.1% +$3.46K 0.67% 45
2022
Q4
$4.09M Sell
56,840
-511
-0.9% -$38.5K 0.75% 44
2022
Q3
$4.08M Sell
57,351
-21
-0% -$1.52K 0.8% 38
2022
Q2
$4.42M Sell
57,372
-1,321
-2% -$101K 0.84% 38
2022
Q1
$4.29M Sell
58,693
-3,545
-6% -$238K 0.68% 46
2021
Q4
$3.88M Sell
62,238
-2,633
-4% -$154K 0.56% 50
2021
Q3
$3.84M Sell
64,871
-14,660
-18% -$965K 0.6% 48
2021
Q2
$5.31M Sell
79,531
-3,496
-4% -$228K 0.84% 38
2021
Q1
$5.24M Sell
83,027
-4,545
-5% -$283K 0.88% 37
2020
Q4
$5.43M Sell
87,572
-2,621
-3% -$161K 0.97% 30
2020
Q3
$5.44M Sell
90,193
-5,165
-5% -$311K 1.09% 26
2020
Q2
$5.61M Sell
95,358
-1,381
-1% -$82.6K 1.24% 23
2020
Q1
$5.39M Sell
96,739
-2,681
-3% -$164K 1.46% 19
2019
Q4
$6.38M Buy
99,420
+35,248
+55% +$2.02M 1.36% 21
2019
Q3
$3.25M Sell
64,172
-1,257
-2% -$59.1K 0.75% 44
2019
Q2
$2.97M Sell
65,429
-2,831
-4% -$132K 0.69% 47
2019
Q1
$3.26M Sell
68,260
-1,446
-2% -$72K 0.79% 43
2018
Q4
$3.62M Sell
69,706
-3,595
-5% -$193K 1.02% 30
2018
Q3
$4.55M Sell
73,301
-2,875
-4% -$171K 1.07% 29
2018
Q2
$4.22M Sell
76,176
-65,024
-46% -$3.51M 1.07% 29
2018
Q1
$8.93M Sell
141,200
-2,012
-1% -$129K 2.29% 5
2017
Q4
$8.78M Sell
143,212
-1,958
-1% -$122K 2.23% 5
2017
Q3
$9.25M Sell
145,170
-3,060
-2% -$179K 2.47% 5
2017
Q2
$8.26M Sell
148,230
-1,250
-0.8% -$68K 2.23% 6
2017
Q1
$8.13M Sell
149,480
-3,244
-2% -$178K 2.24% 7
2016
Q4
$8.93M Sell
152,724
-1,875
-1% -$103K 2.62% 7
2016
Q3
$8.34M Sell
154,599
-10,359
-6% -$665K 2.57% 7
2016
Q2
$12.1M Sell
164,958
-388
-0.2% -$27.4K 3.7% 2
2016
Q1
$10.6M Sell
165,346
-490
-0.3% -$30.9K 3.36% 3
2015
Q4
$11.4M Sell
165,836
-3,791
-2% -$251K 3.62% 3
2015
Q3
$10M Sell
169,627
-1,091
-0.6% -$69.2K 3.44% 3
2015
Q2
$11.4M Sell
170,718
-4,111
-2% -$271K 3.72% 3
2015
Q1
$11.3M Sell
174,829
-1,365
-0.8% -$85.5K 3.7% 3
2014
Q4
$10.4M Sell
176,194
-3,675
-2% -$207K 3.42% 3
2014
Q3
$9.21M Sell
179,869
-6,476
-3% -$323K 3.11% 4
2014
Q2
$9.04M Sell
186,345
-3,411
-2% -$168K 3% 6
2014
Q1
$9.86M Sell
189,756
-2,721
-1% -$145K 3.5% 2
2013
Q4
$10.2M Sell
192,477
-2,366
-1% -$121K 3.55% 4
2013
Q3
$9.02M Sell
194,843
-751
-0.4% -$33K 3.45% 2
2013
Q2
$8.74M Buy
+195,594
New +$8.49M 3.59% 2

Other funds holding BMY

J.W. Burns & Co's BMY Position: Q2 2026 in Review

J.W. Burns & Co reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, selling an estimated $18.1K and leaving 26,774 shares worth $1.54M. The position accounts for 0.16% of the portfolio, ranked #84.

J.W. Burns & Co first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.1M in Q2 2016. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • J.W. Burns & Co held 26,774 shares of Bristol-Myers Squibb worth $1.54M as of Q2 2026.
  • J.W. Burns & Co sold 315 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.1K.
  • Bristol-Myers Squibb made up 0.16% of J.W. Burns & Co's portfolio in Q2 2026, its #84 holding.
  • J.W. Burns & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • J.W. Burns & Co's Bristol-Myers Squibb position peaked at $12.1M in Q2 2016.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on J.W. Burns & Co's 13F filing for Q2 2026, filed 15 Jul 2026.